Wait for results for 1-3 patients14 Jul 2024 16:33
Well I think no point anyone worrying about the share price at the moment, we have to wait for the results of the first 1-3 patients. As terrible as the sp is I think just acceptance is needed now. Worry more about the results of the clinical trial not the current share price. I'm jealous of the price new investors can get in for but there is risk. It's almost like placing a bet at this stage, if results are good then it could be a life changing jackpot, if results are bad then you're in trouble!
If results were good it could genuinely be like hitting the jackpot, going by any of the deals in the pharma space, they are huge. Suddenly hemo will have something very valuable and I would think funding would follow, but don't know when, but they'll need money to continue anyway so they must get something pretty quick. Or a placing of course maybe to tick over but I would accept that if the sp was much higher.
Of course if we get poor results in the 1st patients then we're in trouble, the share price will tank and we'll all be miserable. What happens then I don't know but I would guess Vlad would be forced to sell part of an asset for a knockdown price to keep going, so we'd get some income that way. Going bust seems unlikely to me with the assets they have but who knows... so its misery for a while at least but he might be able to get things better...
That broker note gave me confidence - fair value around 6.5p now and 8p when clinical trials start. So what fair value sp if trials are a success???
Vlad looked very well in I think the last interview as was mentioned by someone on here, he looked much better than just after the CH lift, which must have been stressful, he doesn't look stressed now! Hopefully a good sign.